Add time:08/14/2019         Source:sciencedirect.com

PurposePrevious studies have demonstrated the technical feasibility of destroying prostate tissue using photodynamic therapy for benign and malignant disease. A series of canine studies was performed to evaluate the systemic uptake and distribution of the photosensitizer tin ethyl etiopurpurin (SnET2) in the prostate and surrounding tissues, and determine the optimal combination of drug dose, light dose and time interval between drug and light administration using transurethral and transperineal interstitial light delivery.

We also recommend Trading Suppliers and Manufacturers of tin etiopurpurin (cas 113471-15-1). Pls Click Website Link as below: cas 113471-15-1 suppliers